PIK3C3 and melanoma: In fact, in melanoma models, as the VPS34 kinase inhibitors SB02024 or SAR405 induced a rise in CCL5, CXCL10 and IFN‐γ in the TME along with an increase in the extent of NK and T‐cell infiltration, the inhibition of melanoma was greatly enhanced.